We are live on
!
Find out more
LCM
LionEye Capital Management Portfolio holdings
AUM
$57.4M
1-Year Est. Return
28.02%
This Fund
S&P 500
This Quarter
Est. Return
-16.46%
1 Year Est. Return
-28.02%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.41B
AUM Growth
-$164M
(-6.4%)
Cap. Flow
+$167M
Cap. Flow
% of AUM
6.92%
Top 10 Holdings %
Top 10 Hldgs %
76.96%
Holding
57
New
13
Increased
20
Reduced
4
Closed
17
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HMHC
Houghton Mifflin Harcourt Company
HMHC
|
+$62.3M |
| 2 |
MW
THE MENS WAREHOUSE INC
MW
|
+$53.2M |
| 3 |
FOE
Ferro Corporation
FOE
|
+$53.1M |
| 4 |
iShares Biotechnology ETF
IBB
|
+$32.4M |
| 5 |
AXLL
AXIALL CORP COM STK (DE)
AXLL
|
+$23M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$65M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$48M |
| 3 |
Air Products & Chemicals
APD
|
+$37.4M |
| 4 |
Applied Materials
AMAT
|
+$36.5M |
| 5 |
SPLS
Staples Inc
SPLS
|
+$24.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 16.84% |
| 2 | Industrials | 12.03% |
| 3 | Communication Services | 5.03% |
| 4 | Technology | 2.32% |
| 5 | Energy | 1.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WRK
26
DELISTED
WestRock Company
WRK
| $12.9M | 0.54% |
+279,266
| New | +$15M |
|
27
SPDR Gold Trust
GLD
$141B
| $11.8M | 0.49% |
110,000
+40,000
| +57% | +$4.31M |
|
28
CALL
United Parks & Resorts
PRKS
$2.12B
| $10.7M | 0.44% |
+600,000
| New | +$10.8M |
|
29
Skyworks Solutions
SWKS
$10.6B
| $9.26M | 0.38% |
+110,000
| New | +$10.1M |
|
|
IDTI
30
DELISTED
Integrated Device Technology I
IDTI
| $9.13M | 0.38% |
+450,000
| New | +$8.81M |
|
31
CALL
Microsoft
MSFT
$3.71T
| $8.85M | 0.37% |
+200,000
| New | +$8.98M |
|
32
Magnachip Semiconductor
MX
$145M
| $8.02M | 0.33% |
+1,216,478
| New | +$10.1M |
|
|
TRCO
33
DELISTED
TRIBUNE MEDIA COMPANY CLASS A
TRCO
| $6.49M | 0.27% |
+182,302
| New | +$8.11M |
|
34
Zoetis
ZTS
$30B
| $5.15M | 0.21% |
125,000
+65,000
| +108% | +$3.01M |
|
|
SPLS
35
DELISTED
Staples Inc
SPLS
| $4.11M | 0.17% |
350,000
-1,750,000
| -83% | -$24.6M |
|
36
Perrigo
PRGO
$1.78B
| $3.15M | 0.13% |
+20,000
| New | +$3.67M |
|
37
Element Solutions
ESI
$9.23B
| $2.59M | 0.11% |
+204,500
| New | +$4.21M |
|
|
VER
38
DELISTED
VEREIT, Inc.
VER
| $1.2M | 0.05% |
31,097
-43,406
| -58% | -$1.81M |
|
|
SUNE
39
DELISTED
SUNEDISON, INC COM
SUNE
| $1.08M | 0.04% |
+150,000
| New | +$2.69M |
|
|
40
CALL
Applied Materials
AMAT
$428B
| – | – |
-200,000
| Closed | -$3.84M |
|
|
41
Applied Materials
AMAT
$428B
| – | – |
-1,900,000
| Closed | -$36.5M |
|
|
42
Air Products & Chemicals
APD
$67.6B
| – | – |
-295,221
| Closed | -$37.4M |
|
43
Brink's
BCO
$4.62B
| – | – |
-119,500
| Closed | -$3.52M |
|
44
Herc Holdings
HRI
$5.61B
| – | – |
-350,133
| Closed | -$19M |
|
45
PUT
Royal Bank of Canada
RY
$293B
| – | – |
-100,000
| Closed | -$6.12M |
|
|
46
Teva Pharmaceuticals
TEVA
$41.2B
| – | – |
-1,100,000
| Closed | -$65M |
|
47
iShares 20+ Year Treasury Bond ETF
TLT
$41.7B
| – | – |
-20,000
| Closed | -$2.35M |
|
48
ProShares Ultra VIX Short-Term Futures ETF
UVXY
$228M
| – | – |
0
| – | -$1.5M |
|
49
Visteon
VC
$2.78B
| – | – |
-34,306
| Closed | -$3.6M |
|
|
BERY
50
DELISTED
Berry Global Group, Inc.
BERY
| – | – |
-615,285
| Closed | -$18.3M |
|
Similar funds
OCM
MCA
KCM
RTIM
MCM
GCG
CGC
ST
LionEye Capital Management's Q3 2015 Portfolio in Review
As of Q3 2015, LionEye Capital Management held 57 positions worth $2.41B, down 6.4% from $2.58B the previous quarter. Its ten largest holdings account for 77% of the portfolio.
LionEye Capital Management deployed $167M of net new capital in Q3 2015, opening 13 new positions and adding to 20 existing holdings. Its largest new stake was iShares Biotechnology ETF: 270,000 shares worth $27.3M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, up from 16% a quarter earlier, followed by Industrials and Communication Services.
On the sell side, the largest reduction was Staples Inc, an estimated $24.6M trimmed.
- LionEye Capital Management's largest Q3 2015 buy was iShares Biotechnology ETF: 270,000 shares worth $27.3M.
- LionEye Capital Management added most to Houghton Mifflin Harcourt Company in Q3 2015, an estimated $62.3M increase.
- LionEye Capital Management's biggest Q3 2015 reduction was Staples Inc, cutting an estimated $24.6M.
- LionEye Capital Management fully exited Teva Pharmaceuticals in Q3 2015, selling an estimated $65M.
- LionEye Capital Management's ten largest holdings make up 77% of its $2.41B portfolio in Q3 2015.
- LionEye Capital Management opened 13 new positions and closed 17 in Q3 2015.
- LionEye Capital Management's portfolio value fell 6.4% quarter-over-quarter to $2.41B.
Based on LionEye Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.